Emanuele Irelli-Cerulli

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 78 publications

The Menopause Transition and Epilepsy: A Focus on Therapeutics.

The Menopause Transition and Epilepsy: A Focus on Therapeutics.

Journal: Neurology. Clinical practice

Published: August 13, 2026

Refining diagnostic boundaries and electroclinical profiles of Lennox-Gastaut syndrome through unsupervised clustering.

Refining diagnostic boundaries and electroclinical profiles of Lennox-Gastaut syndrome through unsupervised clustering.

Journal: Epilepsia

Published: May 12, 2026

SUDEP and mortality in developmental and epileptic encephalopathies: A meta-analysis of randomized clinical trials and extension studies.

SUDEP and mortality in developmental and epileptic encephalopathies: A meta-analysis of randomized clinical trials and extension studies.

Journal: Epilepsia

Published: April 09, 2026

Longitudinal Evaluation of Neurological and Sensory Changes in Gaucher Disease: A Prospective Observational Cohort Study (SENOPRO).

Longitudinal Evaluation of Neurological and Sensory Changes in Gaucher Disease: A Prospective Observational Cohort Study (SENOPRO).

Journal: Medical sciences (Basel, Switzerland)

Published: February 23, 2026

Real-world effectiveness and tolerability of highly purified cannabidiol in patients with monogenic developmental and epileptic encephalopathies with highly active epilepsy.

Real-world effectiveness and tolerability of highly purified cannabidiol in patients with monogenic developmental and epileptic encephalopathies with highly active epilepsy.

Journal: Epilepsy & behavior : E&B

Published: February 10, 2026

Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal Epilepsy.

Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal Epilepsy.

Journal: JAMA neurology

Published: February 09, 2026

Do Cenobamate Pharmacokinetics Change with Co-Administered Antiseizure Medications? An Exploratory Analysis of Responder Patients with Focal Drug-Resistant Epilepsy.

Do Cenobamate Pharmacokinetics Change with Co-Administered Antiseizure Medications? An Exploratory Analysis of Responder Patients with Focal Drug-Resistant Epilepsy.

Journal: Pharmaceutics

Published: December 24, 2025

Comparative efficacy of agomelatine and escitalopram in people with epilepsy and comorbid major depressive disorder: A double-blind randomized controlled trial.

Comparative efficacy of agomelatine and escitalopram in people with epilepsy and comorbid major depressive disorder: A double-blind randomized controlled trial.

Journal: Epilepsy & behavior reports

Published: October 30, 2025

Real-world effectiveness of highly purified cannabidiol in epilepsy associated with 15q11.2-q13.1 duplication and deletion syndromes: A multicenter study.

Real-world effectiveness of highly purified cannabidiol in epilepsy associated with 15q11.2-q13.1 duplication and deletion syndromes: A multicenter study.

Journal: Epilepsia open

Published: September 08, 2025

Clinical predictors and concomitant antiseizure medications effects on seizure control in relation to plasma cenobamate concentration: a multicenter retrospective study.

Clinical predictors and concomitant antiseizure medications effects on seizure control in relation to plasma cenobamate concentration: a multicenter retrospective study.

Journal: Frontiers in pharmacology

Published: July 17, 2025

Clinical and genetic landscape of epilepsies with absence seizures and single-gene etiology.

Clinical and genetic landscape of epilepsies with absence seizures and single-gene etiology.

Journal: Epilepsia

Published: June 24, 2025

Sex differences in antiseizure medications response in people with epilepsy: a systematic review.

Sex differences in antiseizure medications response in people with epilepsy: a systematic review.

Journal: Journal of neurology

Published: June 04, 2025

Showing 1-12 of 78

Last Updated: 09/26/2026